Adcirca

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

New Delhi, February 05, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…

6 years ago